1-12793457-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_023013.4(PRAMEF1):c.230C>T(p.Thr77Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,609,380 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023013.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRAMEF1 | NM_023013.4 | c.230C>T | p.Thr77Ile | missense_variant | 2/4 | ENST00000332296.7 | NP_075389.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRAMEF1 | ENST00000332296.7 | c.230C>T | p.Thr77Ile | missense_variant | 2/4 | 1 | NM_023013.4 | ENSP00000332134 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151168Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000764 AC: 19AN: 248630Hom.: 1 AF XY: 0.0000891 AC XY: 12AN XY: 134672
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1458092Hom.: 2 Cov.: 34 AF XY: 0.0000386 AC XY: 28AN XY: 725296
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151288Hom.: 1 Cov.: 31 AF XY: 0.0000406 AC XY: 3AN XY: 73898
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.230C>T (p.T77I) alteration is located in exon 2 (coding exon 1) of the PRAMEF1 gene. This alteration results from a C to T substitution at nucleotide position 230, causing the threonine (T) at amino acid position 77 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at